Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent AE Krausz, BL Adler, V Cabral, M Navati, J Doerner, RA Charafeddine, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (1), 195-206, 2015 | 511 | 2015 |
Unique and redundant functions of integrins in the epidermis C Margadant, RA Charafeddine, A Sonnenberg The FASEB Journal 24 (11), 4133-4152, 2010 | 186 | 2010 |
Human Fidgetin is a microtubule severing the enzyme and minus-end depolymerase that regulates mitosis S Mukherjee, JDD Valencia, S Stewman, J Metz, S Monnier, U Rath, ... Cell cycle 11 (12), 2359-2366, 2012 | 96 | 2012 |
Local control of intracellular microtubule dynamics by EB1 photodissociation J van Haren, RA Charafeddine, A Ettinger, H Wang, KM Hahn, T Wittmann Nature cell biology 20 (3), 252-261, 2018 | 78 | 2018 |
Fidgetin-like 2: a microtubule-based regulator of wound healing RA Charafeddine, J Makdisi, D Schairer, BP O'rourke, JD Diaz-Valencia, ... Journal of Investigative Dermatology 135 (9), 2309-2318, 2015 | 69 | 2015 |
pHLARE: a new biosensor reveals decreased lysosome pH in cancer cells BA Webb, FM Aloisio, RA Charafeddine, J Cook, T Wittmann, DL Barber Molecular biology of the cell 32 (2), 131-142, 2021 | 39 | 2021 |
Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1 Y Wang, B Wu, P Lu, D Zhang, B Wu, S Varshney, G del Monte-Nieto, ... Nature communications 8 (1), 578, 2017 | 34 | 2017 |
Tau repeat regions contain conserved histidine residues that modulate microtubule-binding in response to changes in pH RA Charafeddine, WA Cortopassi, P Lak, R Tan, RJ McKenney, ... Journal of Biological Chemistry 294 (22), 8779-8790, 2019 | 18 | 2019 |
Targeting microtubules for wound repair RA Charafeddine, JD Nosanchuk, DJ Sharp Advances in wound care 5 (10), 444-454, 2016 | 17 | 2016 |
Fidgetin-like 2 negatively regulates axonal growth and can be targeted to promote functional nerve regeneration L Baker, M Tar, AH Kramer, GA Villegas, RA Charafeddine, O Vafaeva, ... Jci Insight 6 (9), 2021 | 12 | 2021 |
Nanomed.: Nanotechnol AE Krausz, BL Adler, V Cabral, M Navati, J Doerner, RA Charafeddine, ... Biol. Med 11, 195, 2015 | 9 | 2015 |
Growth cone advance requires EB1 as revealed by genomic replacement with a light-sensitive variant A Dema, R Charafeddine, S Rahgozar, J van Haren, T Wittmann Elife 12, e84143, 2023 | 7 | 2023 |
Fidgetin-like 2 as a target to enhance wound healing DJ Sharp, R Charafeddine US Patent 9,914,926, 2018 | 7 | 2018 |
Fidgetin-like 2 as a target to enhance wound healing DJ Sharp, R Charafeddine US Patent 9,279,124, 2016 | 7 | 2016 |
Fidgetin-like 2 as a target to enhance wound healing DJ Sharp, R Charafeddine US Patent 8,853,181, 2014 | 6 | 2014 |
Fidgetin-like 2 as a target to enhance wound healing DJ Sharp, R Charafeddine US Patent 10,221,419, 2019 | 4 | 2019 |
Fidgetin-like 2: A novel microtubule-based regulator of wound healing and vasculogenesis RA Charafeddine ProQuest Dissertations & Theses, 2015 | 3 | 2015 |
Fidgetin-like 2 as a target to enhance wound healing DJ Sharp, R Charafeddine US Patent 10,889,820, 2021 | 2 | 2021 |
Fidgetin-like 2 as a target to enhance wound healing DJ Sharp, R Charafeddine US Patent 10,808,250, 2020 | 1 | 2020 |
Fidgetin-like 2 is a novel negative regulator of axonal growth and can be targeted to promote functional nerve regeneration after injury L Baker, M Tar, G Villegas, R Charafeddine, A Kramer, O Vafaeva, ... bioRxiv, 2020.03. 19.999508, 2020 | 1 | 2020 |